[{"Assets_0_Q2_USD":62155000.0,"CommonStockSharesOutstanding_0_Q2_shares":145619293.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-48800000.0,"NetIncomeLoss_1_Q2_USD":-22675000.0,"NetIncomeLoss_2_Q2_USD":-53060000.0,"StockholdersEquity_0_Q2_USD":-206619000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3893000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7358000.0,"Ticker":"MNKD","CIK":"899460","name":"MANNKIND CORP","OfficialName":"MannKind Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898029416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]